Solid Biosciences Shares Are Trading Higher After JP Morgan Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $10 to $15.
Solid Biosciences Shares Are Trading Higher After JP Morgan Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $10 to $15.
solid biosciences股票价格上涨，JP摩根将其评级由中立升级为增持，并将价格目标从10美元上调至15美元。
Solid Biosciences Shares Are Trading Higher After JP Morgan Upgraded the Stock From Neutral to Overweight and Raised Its Price Target From $10 to $15.
solid biosciences股票价格上涨，JP摩根将其评级由中立升级为增持，并将价格目标从10美元上调至15美元。